Literature DB >> 16176273

Human ATP-dependent RNA/DNA helicase hSuv3p interacts with the cofactor of survivin HBXIP.

Michal Minczuk1, Seweryn Mroczek, Sebastian D Pawlak, Piotr P Stepien.   

Abstract

The human SUV3gene encodes an NTP-dependent DNA/RNA DExH box helicase predominantly localized in mitochondria. Its orthologue in yeast is a component of the mitochondrial degradosome complex involved in the mtRNA decay pathway. In contrast to this, the physiological function of human SUV3 remains to be elucidated. In this report we demonstrate that the hSuv3 protein interacts with HBXIP, previously identified as a cofactor of survivin in suppression of apoptosis and as a protein that binds the HBx protein encoded by the hepatitis B virus. Using deletion analysis we identified the region within the hSuv3 protein, which is responsible for binding to HBXIP. The HBXIP binding domain was found to be important for mitochondrial import and stability of the Suv3 protein in vivo. We discuss the possible involvement of the hSuv3p-HBXIP interaction in the survivin-dependent antiapoptotic pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176273     DOI: 10.1111/j.1742-4658.2005.04910.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  14 in total

1.  The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.

Authors:  Shuangping Liu; Leilei Li; Yingyi Zhang; Yiwen Zhang; Yu Zhao; Xiaona You; Zhenhua Lin; Xiaodong Zhang; Lihong Ye
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

2.  Mitochondrial helicases and mitochondrial genome maintenance.

Authors:  Nadja C de Souza-Pinto; Maria D Aamann; Tomasz Kulikowicz; Tinna V Stevnsner; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2010-05-31       Impact factor: 5.432

3.  miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.

Authors:  Nan Hu; Jianli Zhang; Wenjing Cui; Guangyao Kong; Shuai Zhang; Lin Yue; Xiao Bai; Zhao Zhang; Weiying Zhang; Xiaodong Zhang; Lihong Ye
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

4.  Human Suv3 protein reveals unique features among SF2 helicases.

Authors:  Robert Jedrzejczak; Jiawei Wang; Miroslawa Dauter; Roman J Szczesny; Piotr P Stepien; Zbigniew Dauter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-10-19

5.  The human Suv3 helicase interacts with replication protein A and flap endonuclease 1 in the nucleus.

Authors:  Susanne T Venø; Tomasz Kulikowicz; Cezar Pestana; Piotr P Stepien; Tinna Stevnsner; Vilhelm A Bohr
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

6.  Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.

Authors:  Honggang Xia; Lan Ma; Jing Li; Hongyu Bai; Dongbin Wang
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

7.  Disruption of Supv3L1 damages the skin and causes sarcopenia, loss of fat, and death.

Authors:  Erin Paul; Rachel Cronan; Paula J Weston; Kim Boekelheide; John M Sedivy; Sang-Yun Lee; David L Wiest; Murray B Resnick; Jan E Klysik
Journal:  Mamm Genome       Date:  2009-01-15       Impact factor: 2.957

8.  Widespread expression of the Supv3L1 mitochondrial RNA helicase in the mouse.

Authors:  Erin Paul; Marissa Kielbasinski; John M Sedivy; Carlos Murga-Zamalloa; Hemant Khanna; Jan E Klysik
Journal:  Transgenic Res       Date:  2009-11-25       Impact factor: 2.788

Review 9.  Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications.

Authors:  Jin-Qiang Chen; Patrick R Cammarata; Christopher P Baines; James D Yager
Journal:  Biochim Biophys Acta       Date:  2009-06-23

10.  The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells.

Authors:  Lin Yue; Leilei Li; Fangfang Liu; Nan Hu; Weiying Zhang; Xiao Bai; Yinghui Li; Yingyi Zhang; Li Fu; Xiaodong Zhang; Lihong Ye
Journal:  Carcinogenesis       Date:  2013-01-05       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.